Despite the availability of new classes of glucose-lowering drugs, insulin therapy still represents a cornerstone of the treatment for type 2 diabetes mellitus (T2D), and many patients eventually require and benefit from insulin therapy. The gene discussed is INS; the disease is type 2 diabetes mellitus.